eGenesis, Inc. — Form D

eGenesis, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2024-02-27. The offering totals $28.7M, of which $25.4M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (30)

Showing 25 of 30 people.

NameRoleLocation
Michael CurtisDirectorCAMBRIDGE, MA
Kathleen FanningDirectorCAMBRIDGE, MA
Steven GillisDirectorSouth San Francisco, CA
Lucio IannoneDirectorWatertown, MA
Rahul KakkarDirectorCAMBRIDGE, MA
Mark PruzanskiDirectorCAMBRIDGE, MA
Sarah SchlesingerDirectorCAMBRIDGE, MA
Paul SekhriDirectorNew York, NY
Brad SmithDirectorCAMBRIDGE, MA
Julie SunderlandDirectorCAMBRIDGE, MA
Albert WiegmanDirectorCAMBRIDGE, MA
Jennifer BergheiserExecutive OfficerCAMBRIDGE, MA
Michael CurtisExecutive OfficerCAMBRIDGE, MA
Bob MoreDirectorVenice, CA
Boris NikolicDirectorAtlanta, GA
Geoff MacKayExecutive OfficerToronto, A6
Sapna SrivastavaExecutive OfficerBethesda, MD
Paul SekhriExecutive OfficerNew York, NY
Kenneth FanExecutive OfficerDover, DE
Peter HansonExecutive OfficerCAMBRIDGE, MA
Isaac CiechanoverDirectorCAMBRIDGE, MA
Ariel JasieExecutive OfficerCAMBRIDGE, MA
Albert L WiegmanDirectorCAMBRIDGE, MA
Juergen L EckhardtDirectorCAMBRIDGE, MA
Lucio L IannoneDirectorCAMBRIDGE, MA

Other filings by this issuer (4)

FiledFormOfferingSold
2021-03-10D$125.0M$125.0M
2019-11-14D$100.0M$100.0M
2017-03-23D$38.2M$12.6M
2016-08-23D$3.0M$2.0M

More